Alere Inc. (ALR) - Financial and Strategic SWOT Analysis Review

Date: September 27, 2016
Pages: 67
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A59730D7204EN
Leaflet:

Download PDF Leaflet

Alere Inc. (ALR) - Financial and Strategic SWOT Analysis Review
Alere Inc. (ALR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Alere Inc. (Alere) is one of the leading providers of point-of-care diagnostics solutions and services with focus on cardiology, women’s health, infectious diseases, diabetes, oncology, and toxicology. It offers testing and monitoring products including point-of-care and laboratory tests within the infectious disease, cardiometabolic disease, toxicology and patient self-testing domains. It also offers diabetic testing supplies, including blood glucose monitors, test strips, lancets, lancing devices, and control solutions, and other related medical supplies in the US. Alere offers its products and services to hospitals, reference laboratories, point-of-care settings, self-insured employees, wholesale and retail drug stores, and mass merchandisers. The company operates through subsidiaries and a network of distributors in the Americas, Europe, the Middle East, Asia-Pacific and Africa. Alere is headquartered in Waltham, Massachusetts, the US.

Alere Inc. Key Recent Developments

Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results
Aug 25, 2016: Alere Recalls INRatio and INRatio2 PT/INR Monitoring System Due to Incorrect Test Results
Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results
Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results
Aug 01, 2016: Alere Opens New Diagnostics Manufacturing Facility in India

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Alere Inc. - Key Facts
Alere Inc. - Key Employees
Alere Inc. - Key Employee Biographies
Alere Inc. - Major Products and Services
Alere Inc. - Medical Equipment Pipeline Products Data
Alere Inc. Pipeline Products by Equipment Type
Alere Inc. Pipeline Products by Development Stage
Alere Inc. - History
Alere Inc. - Company Statement
Alere Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Alere Inc. - Business Description
Alere Inc. - Corporate Strategy
Alere Inc. - SWOT Analysis
SWOT Analysis - Overview
Alere Inc. - Strengths
Strength - Professional Diagnostics Division
Strength - Focused Research and Development Activities
Strength - Strategic Acquisitions
Strength - Established Presence in North America
Alere Inc. - Weaknesses
Weakness - Patent Infringement Concerns
Weakness - Safety Issues:/Product Defects
Alere Inc. - Opportunities
Opportunity - Regulatory Approvals and New Product Launches
Opportunity - Growing Point-of-Care Testing Market
Opportunity - Growing Clinical Laboratory Testing Industry
Alere Inc. - Threats
Threat - Stringent Government Regulations
Threat - Substantial Debt
Threat - Stiff Competition
Alere Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Alere Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Alere Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Alere Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Alere Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results
Aug 25, 2016: Alere Recalls INRatio and INRatio2 PT/INR Monitoring System Due to Incorrect Test Results
Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results
Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results
Aug 01, 2016: Alere Opens New Diagnostics Manufacturing Facility in India
Jun 13, 2016: U.S. HHS approves Alere Richmond, VA Laboratory for eCCF paperless process
Mar 18, 2016: Alere Comments on Alere Anticoagulation Monitoring Technology
Nov 04, 2015: Alere Reports Third Quarter 2015 Financial Results
Oct 15, 2015: Alere Receives U.S. HHS Approval to Electronically Process Drug Tests for Department of Transportation-Regulated Employees
Aug 13, 2015: Alere Partners with Desmond Tutu HIV Foundation to Reduce Impact of Disease on Vulnerable Youth

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Alere Inc., Key Facts
Alere Inc., Key Employees
Alere Inc., Key Employee Biographies
Alere Inc., Major Products and Services
Alere Inc. Pipeline Products by Equipment Type
Alere Inc. Number of Pipeline Products by Development Stage
Alere Inc. Pipeline Products Summary by Development Stage
Alere Inc., History
Alere Inc., Subsidiaries
Alere Inc., Key Competitors
Alere Inc., Ratios based on current share price
Alere Inc., Annual Ratios
Alere Inc., Interim Ratios
Alere Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Alere Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Alere Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Alere Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Alere Inc. Pipeline Products by Equipment Type
Alere Inc. Pipeline Products by Development Stage
Alere Inc., Performance Chart (2011 - 2015)
Alere Inc., Ratio Charts
Alere Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Alere Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Alere Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Alere Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Siemens Healthcare GmbH
Remel Inc.
OraSure Technologies, Inc.
Meridian Bioscience, Inc.
Johnson & Johnson
Inova Diagnostics, Inc.
Healthways, Inc.
Health Dialog Services Corporation
F. Hoffmann-La Roche Ltd.
Diamedix Corporation
Cepheid
Bio-Rad Laboratories, Inc.
Biokit, S.A.
Biokit USA Inc.
Beckman Coulter, Inc.
Abbott Laboratories
Abaxis, Inc.
Skip to top


Ask Your Question

Alere Inc. (ALR) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: